High dietary n-6 / n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 463-471

  Liang, Zhang ^a   Yue, Geng ^a   Ning, Xiao ^a   Miao, Yin ^a   Liufeng, Mao ^a   Guocheng, Ren ^a   Cong, Zhang ^a   Peng, Liu ^a   Nannan, Lu ^a   Liguo, An ^a   Jie, Pan ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Alpha linolenic acid; Linoleic acid; Liver; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR ALPHA; MESSENGER RNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIET THERAPY; ENZYME ACTIVITY; FAT INTAKE; GENETIC TRANSCRIPTION; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; THERAPY EFFECT; UPREGULATION;

EID: 73249150534     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.no1347     Document Type: Article

References (42)

1. Fernandez ML, West KL: Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr, 2005; 135: 2075-2078
2. Sacks FM, Campos H: Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. J Clin Endocrinol Metab, 2006; 91: 398-400
3. Aggett PJ, Haschke F, Heine W, Hernell O, Koletzko B, Launiala K, Rey J, Rubino A, Schöch Senterre, et al: Comment on the content and composition of lipids in infant formulas. ESPGAN Committee on Nutrition. Acta Paediatr Scand, 1991; 80: 887-896
4. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother, 2002; 56: 365-379
5. Wijendran V, Hayes KC: Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr, 2004; 24: 597-615
6. Mooradian AD, Haas MJ, Wong NC: The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev, 2006; 27: 2-16
7. Stein O, Stein Y: Atheroprotective mechanisms of HDL. Atherosclerosis, 1999; 144: 285-301
8. Sarria AJ, Surra JC, Acin S, Carnicer R, Navarro MA, Arbones-Mainar JM, Guillen N, Martinez-Gracia MV, Arnal C, Osada J: Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models. Front Biosci, 2006; 11: 955-967
9. Ly H, Francone OL, Fielding CJ, Shigenaga JK, Moser AH, Grunfeld C, Feingold KR: Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res, 1995; 36: 1254-1263
10. Arbonés-Mainar JM, Navarro MA, Acin S, Guzmán MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J: Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr, 2006; 136: 353-359
11. Burgess B, Naus K, Chan J, Hirsch-Reinshagen V, Tansley G, Matzke L, Chan B, Wilkinson A, Fan J, et al: Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 2008; 28: 1731-1737
12. Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y: Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice. J Pharm Pharmacol, 2006; 58: 1629-1638
13. Nestel P, Fujii A, Allen T: The cis-9, trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis, 2006; 189: 282-287
14. Huggins KW, Colvin PL, Burleson ER, Kelley K, Sawyer JK, Barrett PH, Rudel LL, Parks JS: Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys. J Lipid Res, 2001; 42: 1457-1466
15. Wilkinson P, Leach C, Ah-Sing EE, Hussain N, Miller GJ, Millward DJ, Griffin BA: Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis, 2005; 181: 115-124
16. Alexander Aguilera A, Hernández Diaz G, Lara Barcelata M, Angulo Guerrero O, Oliart Ros RM: Induction of Cd36 expression elicited by fish oil PUFA in spontaneously hypertensive rats. J Nutr Biochem, 2006; 17: 760-765
17. Vasandani C, Kafrouni AI, Caronna A, Bashmakov Y, Gotthardt M, Horton JD, Spady DK: Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J Lipid Res, 2002; 43: 772-784
18. George J, Mulkins M, Casey S, Schatzman R, Sigal E, Harats D: The effects of N-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atherosclerosis. Atherosclerosis, 2000; 150: 285-293
19. Wang HH, Hung TM, Wei J, Chiang AN: Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res, 2004; 61: 169-176
20. -/- double knockout mouse. Thromb Res, 2005; 116: 393-401
21. Sirtori CR, Gatti E, Tremoli E, Galli C, Gianfranceschi G, Franceschini G, Colli S, Maderna P, Marangoni F, Perego P, et al: Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia. Am J Clin Nutr, 1992; 56: 113-122
22. Svensson M, Schmidt EB, Jorgensen KA, Christensen JH: The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant, 2008; 23: 2918-2924
23. Okuda N, Ueshima H, Okayama A, Saitoh S, Nakagawa H, Rodriguez BL, Sakata K, Choudhury SR, Curb JD, Stamler J: Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. Atherosclerosis, 2005; 178: 371-379
24. Benatti P, Peluso G, Nicolai R, Calvani M: Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr, 2004; 23: 281-302
25. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J, 1999; 138: S419-420
26. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease ? Immunol Today, 1995; 16: 27-33
27. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, et al: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest, 2005; 115: 1333-1342
28. Wang N, Lan D, Chen W, Matsuura F, Tall AR: ATPbinding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA, 2004; 101: 9774-9779
29. Kennedy MA, Barrera GC, Nakamura K, Baldán A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA: ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab, 2005; 1: 121-131
30. Vaughan AM, Oram JF: ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem, 2005; 280: 30150-30157
31. Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, Matsuo Y, Rust S, Lorkowski S, Assmann G, et al: Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR / RXR responsive element. Atherosclerosis, 2007; 191: 11-21
32. Ahn YS, Smith D, Osada J, Li Z, Schaefer EJ, Ordovas JM: Dietary fat saturation affects apolipoprotein gene expression and high density lipoprotein size distribution in golden Syrian hamsters. J Nutr, 1994; 124: 2147-2155
33. Azrolan N, Odaka H, Breslow JL, Fisher EA: Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool. J Biol Chem, 1995; 270: 19833-19838
34. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J: The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res, 1997; 38: 191-205
35. Ng DS: Insight into the role of LCAT from mouse models. Rev Endocr Metab Disord, 2004; 5: 311-318
36. Jonas A: Regulation of lecithin cholesterol acyltransferase activity. Prog Lipid Res, 1998; 37: 209-234
37. Vaysse-Boué C, Dabadie H, Peuchant E, Le Ruyet P, Mendy F, Gin H, Combe N: Moderate dietary intake of myristic and alpha-linolenic acids increases lecithin-cholesterol acyltransferase activity in humans. Lipids, 2007; 42: 717-722
38. Parks JS, Bullock BC, Rudel LL: The reactivity of plasma phospholipids with lecithin: cholesterol acyltransferase is decreased in fish oil-fed monkeys. J Biol Chem, 1989; 264: 2545-2551
39. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M: Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature, 1997; 387: 414-417
40. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M: A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA, 1997; 94: 12610-12615
41. Brundert M, Ewert A, Heeren J, Behrendt B, Ramakrishnan R, Greten H, Merkel M, Rinninger F: Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol, 2005; 25: 143-148
42. Spady DK, Kearney DM, Hobbs HH: Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res, 1999; 40: 1384-1394